NSE: NEOGEN | BSE: 542665

Expensive Performer

Download real time

1554.50 1.50 (0.10%)

35.76% Fall from 52W High

22,744 NSE+BSE Volume

NSE 15 May, 2025 3:57 PM (IST)

4,101

Market Cap

Above industry Median

1.0

Beta 1Year

Average volatility

Neogen Chemicals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for NEOGEN, BSE:542665 Neogen Chemicals Ltd.

Neogen Chemicals Ltd.

02 Nov 2021

1554.50

0.10%

Neogen Chemicals Ltd.

Buy: Neogen Chemicals Ltd.

Target

ICICI Securities Limited

manufactures specialty organic bromine-based chemical compounds as well as specialty inorganic lithium-based chemicals compounds. Neogen has two segments viz. (i) organic chemicals, (ii) inorganic chemicals...

Neogen Chemicals Ltd. has an average target of 2271.50 from 2 brokers.

Neogen Chemicals Ltd.

21 Sep 2021

1554.50

0.10%

Neogen Chemicals Ltd.

Buy: Neogen Chemicals Ltd.

Target

ICICI Securities Limited

The asset turn is expected to be around ~2.7x, which provides incremental revenue visibility of ~| 350 crore. Since both these business verticals are margin accretive thus, incremental revenue share from both segments is...

Neogen Chemicals Ltd. has lost -21.66% in the last 6 Months

Neogen Chemicals Ltd.

07 Sep 2021

1554.50

0.10%

Neogen Chemicals (Initiating Coverage): Breaking into the next orbit with a bang. BUY

Buy: Neogen Chemicals Ltd.

HDFC Securities

We expect strong EBITDAand PAT CAGRs of 35/47% over FY22-24E. We initiate coverage on NCL with a BUY and target price of INR 1,220, (WACC 10%, terminal growth 5%). The stock is trading at 43.4/28.0 on FY23/24E EPS. Neogen Chemicals Ltd (NCL) is a leading manufacturer of bromine and lithium-based derivatives in India with technocrat promoters at the helm. We believe the improvement in the share of custom synthesis manufacturing (CSM) and advanced intermediates will result in strengthening of the balance sheet and manifest earnings visibility. The tripling of its organic chemicals manufacturing capacity will not only allow it to fulfil commitments of the two long-term contracts, but also bestow flexibility in selection of new molecules. Capacity expansion will accelerate the pace of growth, which was previously curtailed by limited infrastructure.

Neogen Chemicals Ltd. has an average target of 2271.50 from 2 brokers.

Neogen Chemicals Ltd.

02 Jun 2021

1554.50

0.10%

Neogen Chemicals Ltd. | Q4FY21 Result Update

Buy: Neogen Chemicals Ltd.

Target

Edelweiss

Consistent quarter; capex commissioning to herald growth

Neogen Chemicals Ltd. has an average target of 2271.50 from 2 brokers.

Neogen Chemicals Ltd.

31 Mar 2021

1554.50

0.10%

Neogen Chemicals Ltd.

Buy: Neogen Chemicals Ltd.

ICICI Securities Limited

Both phase 1, 2 expansion at Dahej would expand organic chemical capacity by 3x with a capex of | 130 crore. This would translate into incremental revenue of | 350-375 crore at peak utilisation against overall revenues of | 306 crore currently. We expect the Dahej facility to largely cater to the custom synthesis opportunity with the Vadodara plant catering to advanced intermediates market. Given both these segments have better gross margins compared to the base business, increase in the share of these segments is...

Neogen Chemicals Ltd. has lost -21.66% in the last 6 Months

Neogen Chemicals Ltd.

02 Dec 2020

1554.50

0.10%

Long Term Recommendation | Neogen Chemicals Ltd.

Buy: Neogen Chemicals Ltd.

Edelweiss

Neogen Chemicals (Neogen) is a play on the niche segment of organic bromine derivatives.

Neogen Chemicals Ltd. is trading below all available SMAs

Neogen Chemicals Ltd.

23 Jul 2019

1554.50

0.10%

Visit Update

Not Rated: Neogen Chemicals Ltd.

Prabhudas Lilladhar

We met the management of Neogen Chemicals to get an update on company's growth prospects post stellar initial offering. The company is a leading bromine and lithium based specialty chemicals player with OVER 300...

Neogen Chemicals Ltd. has lost -21.66% in the last 6 Months

VOTE: Is Neogen Chemicals Ltd. worth buying?

42 Votes:

Buy 85.71%

Sell 4.76%

Hold 9.52%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf link